Please login or register first to view this content.
Ophthalmic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
NDA Submitted for MydCombi, a Novel Mydriatic Agent
Tepezza Supply Shortage Expected Soon
Eysuvis Approved for Dry Eye Disease
Cyclosporine Eyedrops Under Review for Vernal Keratoconjunctivitis
Preservative-Free Alaway Gets FDA Approval for OTC Use
Cystadrops Now Available for Patients With Cystinosis
Levodopa Benefits Neovascular Age-Related Macular Degeneration
Cystadrops Approved to Treat Corneal Crystal Deposits in Cystinosis
FDA Warns of Risks Associated With Intraocular Use of Moxifloxacin
EyeArt Autonomous AI System Cleared for Diabetic Retinopathy Screening
Glaucoma Patients Worry About Managing Disease During Pandemic
Olopatadine 0.7% Eye Drops Approved for Sale Over-the-Counter
Upneeq Approved for Acquired Blepharoptosis
Beovu Labeling Updated With Additional Safety Information
Eysuvis Under Review for Dry Eye Disease
Varenicline Nasal Spray Improves Signs, Symptoms of Dry Eye Disease in Trial
Low Doses of Bevacizumab Tested for Retinopathy of Prematurity
Guidance Presented for Contact Lens Use During COVID-19
